Boutwell R K
Cancer Res. 1976 Jul;36(7 PT 2):2631-5.
After an introduction to the "Session on Skin" emphasizing that some early biochemical changes occurring in the two-stage model system for skin would be presented in the three following presentations, several background experiments were discussed. It was shown that a complete carcinogen for the skin (7,12-dimethylbenz[a]anthracene) provides both initiating and promoting components, but as the dose level of the carcinogen is lowered its promoting activity is lost while its initiating activity is retained. At the dose level that is completely carcinogenic, 7,12-dimethylbenz[a]anthracene exhibits the properties of a promoter; it stimulates RNA, protein, and DNA synthesis followed by cell division. At initiating doses, both the biochemical and morphological (increased mitosis) responses to treatment that are characteristic of promoters are lost; the remaining biochemical effects involve DNA and are attributed to initiating action. Some of the data supporting the concept that the mechanism of action of tumor promotion involves gene activation were reviewed.
在对“皮肤专题会议”进行介绍时强调,皮肤两阶段模型系统中发生的一些早期生化变化将在接下来的三个报告中呈现,随后讨论了几个背景实验。结果表明,皮肤的一种完全致癌物(7,12 - 二甲基苯并[a]蒽)兼具引发和促癌成分,但随着致癌物剂量水平降低,其促癌活性丧失而引发活性保留。在完全致癌的剂量水平下,7,12 - 二甲基苯并[a]蒽表现出促癌剂的特性;它刺激RNA、蛋白质和DNA合成,随后引发细胞分裂。在引发剂量下,对促癌剂具有特征性的生化和形态学(有丝分裂增加)反应均丧失;其余的生化效应涉及DNA,并归因于引发作用。回顾了一些支持肿瘤促癌作用机制涉及基因激活这一概念的数据。